Patient tagging device for reducing medical errors gets US nod
This article was originally published in Clinica
Executive Summary
The FDA has cleared for sale in the US a noninvasive tagging system aimed at safeguarding against surgical mishaps. The skin-mounted adhesive, called SurgiChip, is expected to remove the risk of patients being given the wrong surgical procedure or treated at the wrong site of injury. The product's Palm Beach Gardens, Florida based developer, also known as SurgiChip, says the product is the first external surgical marker to implement radiofrequency identification (RFID) technology.